NEW YORK (GenomeWeb) – Fitch Ratings on Friday assigned an A(EXP) rating with a Negative Rating Watch to Abbott Laboratories' notes offering.

The agency said it expects to resolve the (EXP) notation and the rating watch, and to downgrade Abbott to a BBB/F2 rating as more information about the notes offering becomes available. The company said it will use the proceeds to fund its acquisition of St. Jude Medical and to potentially fund its buy of Alere.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.